Past Events

Join us as we reconnect in-person after two long-awaited years. ISCT 2022 will revitalize past networks, spark new connections, and most importantly deliver education bridging together innovative translation, therapeutic design, clinical evaluation, and commercial adoption of cell and gene therapies.

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting, celebrating its 25th year in 2022, is the premier event for professionals in gene and cell therapy.

Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) - Recent breakthroughs in autologous cellular therapies have generated tremendous excitement for the industry; however, these advances have been confronted with the expense of manufacturing of viral gene delivery and concerns over random integration and the safety of viral vectors.

The 2022 ISSCR Annual Meeting, co-sponsored by STEMCELL Technologies, gathers the world's leading scientists, clinicians, business leaders, ethicists, and educators from more than 65 countries.

On behalf of the European Society for Animal Cell Technology I am delighted to invite you to join us in Lisboa, Portugal, for the 27th ESACT meeting to be held from 26th-29th June 2022.

The Believe Ball supports our mission of funding childhood cancer research that will lead to the discovery of more targeted and less toxic treatments for children and raise awareness for childhood cancers, cancer research, and clinical trials. Together, we will Write a Better Story for these heroes!

The International Society for Stem Cell Research (ISSCR) and the American Society for Gene and Cell Therapy (ASGCT) are partnering to host an exciting program on the latest advancements in regenerative medicine at the intersection of genetic and cellular technologies. The marriage of genomic and cellular advances holds tremendous potential for regenerative medicine. Recent discoveries in stem cell biology are being combined with powerful new gene-editing technologies to bring about potentially transformative new therapies for diseases affecting a wide range of tissue and organ systems. This three day meeting will highlight groundbreaking work developing therapies for diseases of the nervous, hematopoietic, and muscle systems, diabetes, metabolic diseases, and cancer, and feature forward-looking new technologies shaping the future of the field. Join us on 21 - 23 September 2022 when world-renowned scientists developing gene and cell therapies will converge in Madison, WI, a city recognized for its seminal contributions to human stem cell research, to present new discoveries at the leading edge of regenerative medicine.

Join us at the largest bioprocessing event for learning how to accelerate promising biologics, cell & gene therapies towards commercial success. Each year, BPI's scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.

The Maryland Life Sciences Bio Innovation Conference will connect top life sciences professionals in the region with leading global brands, venture capitalists and promising startups. Created by life sciences professionals for life sciences professionals, this forum offers an exciting and unique opportunity to reach industry leaders and decision makers across the industry and demonstrate to colleagues and clients how your products or services can lead the way to a healthier tomorrow.

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

This year’s ESGCT has invited speakers across plenary, parallel and keynote sessions will represent the leading individuals and labs active in the field today. The ESGCT Annual Congresses has become known for their cutting-edge science, up-to-date programming, student engagement activities, and their focus on enabling in-depth networking and collaborations across exhibition, fully catered opening and closing events, coffee and lunch breaks, poster sessions and the famed Molecular Mingle. In Edinburgh, this will take place at the National Museum of Scotland where the galleries will be opened for exploring and will showcase the best of local cuisine and entertainment.

Clinical drug candidates must have not only appropriate affinity and target specificity, but also optimal biophysical properties. Using nuclease-directed integration, we constructed large mammalian display libraries where each cell contains a single antibody gene inserted at a single locus. IgG-formatted antibodies are displayed on the surface, permitting selection from the library of clones by FACS, which allows the selection for desirable binding properties in the final format. This system is uniquely sensitive to critical biophysical characteristics, such as aggregation propensity and poly-specificity, thereby enabling the detection and avoidance of problematic antibodies during the initial discovery phase.

Biologic drug discovery, development, manufacturing, pricing & market access, Clinical Trials. The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial challenges involved in bringing new therapies to market.

Join SITC and your colleagues for the leading cancer immunotherapy and tumor immunology conference this Nov. 8–12, 2022 in Boston, MA or virtually. Register today to experience the cutting-edge science presented at SITC 2022.

As the global biopharmaceutical industry continues to grow and evolve, companies are constantly facing pressures to focus on the patient as they improve the quality, efficacy, cost, and compliance of their life-saving products. The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives, cutting-edge technology providers and media partners for North America’s premier biologics event.

The #1 antibody engineering conference for accelerating next generation antibodies to commercial success.